AIMCA
NBIX icon

Alberta Investment Management Corp (AIMCo)’s Neurocrine Biosciences NBIX Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,900
Closed -$262K – 920
2024
Q1 		$262K Hold
1,900
– – ﹤0.01% 937
2023
Q4 		$250K Hold
1,900
– – ﹤0.01% 938
2023
Q3 		$214K Sell
1,900
-80,895
-98% -$8.52M ﹤0.01% 970
2023
Q2 		$7.81M Buy
82,795
+7,777
+10% +$760K 0.08% 238
2023
Q1 		$7.59M Sell
75,018
-4,391
-6% -$457K 0.07% 253
2022
Q4 		$9.48M Sell
79,409
-19,697
-20% -$2.31M 0.08% 264
2022
Q3 		$10.5M Buy
99,106
+67,244
+211% +$6.82M 0.08% 263
2022
Q2 		$3.11M Buy
31,862
+162
+0.5% +$15K 0.02% 612
2022
Q1 		$2.97M Buy
+31,700
New +$2.69M 0.02% 684
2017
Q1 		– Sell
-52,245
Closed -$2.02M – 870
2016
Q4 		$2.02M Buy
52,245
+1,370
+3% +$62K 0.02% 459
2016
Q3 		$2.58M Buy
50,875
+640
+1% +$31.9K 0.03% 393
2016
Q2 		$2.28M Hold
50,235
– – 0.03% 395
2016
Q1 		$1.99M Sell
50,235
-100,722
-67% -$4M 0.03% 382
2015
Q4 		$8.54M Sell
150,957
-7,050
-4% -$358K 0.1% 245
2015
Q3 		$6.29M Sell
158,007
-15,507
-9% -$750K 0.07% 303
2015
Q2 		$8.29M Sell
173,514
-226,363
-57% -$9.6M 0.09% 282
2015
Q1 		$15.9M Buy
+399,877
New +$14.3M 0.17% 156

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s NBIX Position: Q2 2024 in Review

Alberta Investment Management Corp (AIMCo) sold out of Neurocrine Biosciences (NBIX) in Q2 2024, closing a stake of 1,900 shares — an estimated $262K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in NBIX in Q1 2015 and held it in 17 quarters. The position peaked at $15.9M in Q1 2015. 595 funds tracked by Wall St. Rank hold NBIX as of Q2 2024.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Neurocrine Biosciences position as of Q2 2024 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 1,900 Neurocrine Biosciences shares in Q2 2024, an estimated $262K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Neurocrine Biosciences in Q1 2015 and held it in 17 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Neurocrine Biosciences position peaked at $15.9M in Q1 2015.
  • 595 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2024.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2024, filed 13 Aug 2024.